A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study was to evaluate the relative bioavailability of Paddock Laboratories, Inc.'s test formulation of Moexipril/ Hydrochlorothiazide 15mg/25mg tablets with a reference formulation Uniretic®(Moexipril/ Hydrochlorothiazide) 15mg/25mg tablets, under fasting conditions.

Key facts

Study ID

NCT00990301

Run by

Paddock Laboratories, Inc.

People needed

48

Last updated by the study team

2013-11-25

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good health as determined by lack of clinically significant abnormalities in health assessments performed at screening

You may not qualify if…

• Positive test results for HIV or Hepatitis B or C
• History of allergy or sensitivity to Moexipril, Hydrochlorothiazide or related drugs

Where it is running

• Novum Pharmaceutical Research Services — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.